drugset / Trial / NCT03037593

High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women

NCT03037593

Phase 1/2 Withdrawn University of Minnesota
RandomizedSingle-groupOpen-labelTreatment

Summary

Demonstrate dose-dependent relationship between vitamin D supplementation and rates of gestational diabetes.

Timeline

Start
2017-06-01
Primary completion
2020-06
Completion
2020-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 4000 iu

Indications